Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 20, 2008

View Archived Issues

MOTIVATE, MERIT studies detail activity of maraviroc in HIV infection

DUET-1 and DUET-2: Results at 48 weeks with TMC-125 in HIV infection

Cognitive improvement seen with intranasal insulin in early Alzheimer's disease

Atazanavir/ritonavir as effective as lopinavir/ritonavir in treatment-naive HIV patients

Recent patents impart new therapeutic agents for respiratory and allergic disorders

Novel therapeutic options for cancer described in recent patent literature

Novel antiinflammatory agents claimed in recent patents

Pharmexa provides update on company plans

Improved pharmacokinetics of Pfizer's novel long-acting, inhaled beta2 receptor agonist

Chelsea receives SPA for pivotal phase III droxidopa study

Hollis-Eden files IND for Apoptone in hormone-sensitive cancers

Lenalidomide receives orphan drug status in Japan

Roche completes tender offer for Ventana Medical Systems

Bionomics receives USD 1 million milestone payment from Genmab

Memory and Roche to initiate biomarker clinical study of MEM-3454 for schizophrenia

Alligator Bioscience and ImmuRx enter into strategic collaboration

PLx Pharma initiates phase I clinical trial of Aspirin-PC

Potency of sipuleucel-T is reported to be correlated with patient survival

Antitumor mechanism of marine lipopeptide elucidated

Protectan CBLB-502 significantly decreases adverse effects of chemotherapy in mice

FDA accepts NDA for Treanda in relapsed indolent non-Hodgkin's lymphoma

DSMB recommends continuation of Oxford BioMedica's TroVax phase III study

InNexus Biotechnology announces second preclinical antibody targeting cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.